Participation in clinical trials may improve care of acute schizophrenia inpatients in a general hospital

CNS Spectrums

Volumn 13, Issue 9, 2008, Pages 757-761

  Halbreich, Uriel ^a   Smail, Nancy ^a   Tu, Xin ^b   Halbreich, Judith ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; NEUROLEPTIC AGENT;

ACUTE DISEASE; ADULT; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; GENERAL HOSPITAL; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT; SCHIZOPHRENIA; SHORT COURSE THERAPY;

EID: 54349095231     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900013870     Document Type: Article

References (27)

1. Ellis PM. Attitudes towards and participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol. 2000;11:939-945.
2. Hunter CP, Frelick RW, Feldman AR, et al. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treatment Reports. 1997;71:559-565.
3. Antman K, Amato D, Wood W, et al. Selection bias in clinical trials. J Clin Oncol. 1985;3:1142-1147.
4. Ketley D, Woods KL. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 1993;342:891-894.
5. Segelov E, Tatersall MHN, Coats AS. Redressing the balance-the ethics of not entering an eligible patient on a randomized clinical trial. Ann Oncol. 1992;3:103-105.
6. Vinciguerra V, Moore T. Attitudes of CCOP physicians toward clinical trials and protocol accrual. Prog Clin Biol Res. 1990;339:401-407.
7. Baum M. New approach for recruitment into randomized controlled trials. Lancet. 1993;341:812-813.
8. Baum M. Clinical trials-a brave new partnership: a response to Mrs. Thornton. J Med Ethics. 1994;20:23-24.
9. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. Englewood Cliff, NJ: Prentice Hall; 2001.
10. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis-Using the SAS System. Cary, NC: SAS Publishing; 2000.
11. Bickel PJ, Duksum KA. Mathematical Statistics: Basic Ideas and Selected Topics. San Francisco, Calif: Holden-Day; 1977.
12. To XM, Litvak F, Pagano M. Studies of AIDS and HIV surveillance. Screening tests: can we got more by doing less? Stat Med. 1994;13:1905-1919.
13. Addington D, McKenzie F, Addington J, Patten S, Smith H, Adair C. Performance Measures for Early Psychosis Treatment Services. Psychiatr Serv. 2005;56:1570-1582.
14. Hermann RC, Finnerty M, Provost S, et al. Process measures for the assessment and improvement of quality of care for schizophrenia. Schizophr Bull. 2002;28:95-104.
15. Center for Disease Control. OuickStats: average length of hospital stay, by diagnostic category - United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;54;680.
16. Wray NP, Petersen NJ, Souchek J, Ashton CM, Hollingsworth JC, Geraci JM. The hospital multistay rate as an indicator of quality of care. Health Services Research. 1999;34:777-790.
17. Department of Health. 1999 Modern Standards and Service Models. National Service Framework for Mental Health. London, UK: Department of Health; 1999.
18. McEwan K, Goldner EM. Accountability and Performance Indicators for Mental Health Services and Supports: A Resource Kit. Ottawa, Canada: Government Services Canada; 2000.
19. Charlwood P, Mason A, Goldacre M, et al. Health Outcome Indicators: Severe Mental Illness. Oxford, UK: National Centre for Health Outcomes Development; 1999.
20. Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: Initial results from the schizophrenia patient outcomes research team (PORT) client survey. Schizophr Bull. 1998;24:11-20.
21. Australian Clinical Guidelines for Early Psychosis. Melbourne, Australia: National Early Psychosis Project; 2000.
22. Practice guidelines for the treatment of patients with schizophrenia. American Psychiatric Association. Am J Psychiatry. 1997;154(suppl 4):1-63.
23. Young AS, Sullivan G, Burnam MA, et al. Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry. 1998;55:611-617.
24. Slade M, McCrone P, Kuipers E, et al. Use of standardized outcome measures is adult mental health services: randomized controlled trial. Br J Psychiatry. 2006;189:330-336.
25. Trauer T. Routine outcome measurement by mental health care providers. Lancet. 2003;361:1137.
26. Valenstein M, Mitchinson A, Ronis DL, et al. Am J Psychiatry. 2004;161:146-153.
27. Bilsker D, Goldmer EM. Routine outcome measurements by mental health-care providers: is it worth doing? Lancet. 2002;360:1689-1690.